About MVZ Nordhausen
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
AGO Research GmbH
2
AGO Study Group
1
Grupo Español de Investigación en Cáncer de Ovario
1
Clinical Trials at MVZ Nordhausen
During the past decade, MVZ Nordhausen conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer
2013-05-01
2021-01-01
Completed
682
Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer
2018-09-11
2024-12-01
Active, not recruiting
550
Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer
2018-11-21
2025-01-01
Active, not recruiting
414
Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
2022-09-13
2030-09-01
Recruiting
970
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "MVZ Nordhausen"
#1 collaborator was "ARCAGY/ GINECO GROUP" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "AGO Study Group" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator and "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were
collaborators in the rest 11 trials.
Clinical Trials Conditions at MVZ Nordhausen
According to Clinical.Site data, the most researched conditions in "MVZ Nordhausen" are
"Recurrent Ovarian Carcinoma" (2 trials), "Fallopian Tube Cancer" (1 trials), "Ovarian Cancer" (1 trials), "Peritoneal Cancer" (1 trials) and "Recurrent Platinum-sensitive Ovarian Cancer" (1 trials). Many other conditions were trialed in "MVZ Nordhausen" in a lesser frequency.
Clinical Trials Intervention Types at MVZ Nordhausen
Most popular intervention types in "MVZ Nordhausen" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (3 trials), "Carboplatin" (3 trials), "Atezolizumab" (2 trials), "Niraparib" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.
Clinical Trials Genders at MVZ Nordhausen
The vast majority of trials in "MVZ Nordhausen" are
4 trials for "Female" genders.
Clinical Trials Status at MVZ Nordhausen
Currently, there are NaN active trials in "MVZ Nordhausen".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in MVZ Nordhausen,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in MVZ Nordhausen, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".